Please use this identifier to cite or link to this item: http://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5982
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2021-06-28T05:35:20Z
dc.date.available2021-06-28T05:35:20Z
dc.date.issued2020-02en_US
dc.identifier.urihttp://dr.iiserpune.ac.in:8080/xmlui/handle/123456789/5982
dc.description.abstractThe present invention provides an in-vitro process for profiling a combined expression pattern of SATB (special AT-rich sequence-binding protein-1) family chromatin organizers i.e. SATB-1 and SATB-2 as a biomarker tool for cancer prognosis to assess cancer aggressiveness and it progression in an array of cancer types. The combined expression pattern of SATB is established by the method of Kaplan Meier survival analysis of a dataset of patients from a plurality of cancer types. Further, the present invention provides a prognostic kit to evaluate the progression of cancer by using the combined expression pattern of SATB-1 and SATB-2 as a biomarker tool for cancer prognosis.en_US
dc.language.isoenen_US
dc.subjectSATB-1en_US
dc.subjectSATB-2en_US
dc.subject2020en_US
dc.titleCombined expression pattern of SATB family chromatin organizers as improved biomarker tool for cancer prognosisen_US
dc.title.alternativeEvaluating progression and aggressiveness of cancer, e.g. colorectal cancer/colon adenocarcinoma, involves evaluating combined expression levels of special AT-rich sequence-binding protein (SATB)-1 and SATB-2 chromatin organizers (DWPI title)en_US
dc.typePatenten_US
dc.publisher.departmentDept. of Biologyen_US
dc.assigneeIndian Institute of Science Education and Research Puneen_US
dc.identifier.patentnumberIN201821029791Aen_US
dc.application.numberIN201821029791Aen_US
dc.date.application2018-08en_US
dc.publication.kindcodeAen_US
dc.publication.countryINen_US
dc.contributor.inventorGALANDE, SANJEEVen_US
dc.contributor.inventorNAIK, RUTIKAen_US
Appears in Collections:PATENTS

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.